Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Niu

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Scientific Reports|February 15, 2019
Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKDHui Zhang, Hongqin Xu, Ruihong Wu, et al.
Journal of Hepatocellular Carcinoma|October 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese PatientsMiaoxia Liu, Ruihong Wu, Xu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2019
Hepatitis B Virus-Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human MonocytesHongxiao Song, Guangyun Tan, Yang Yang, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Journal of Hepatology|March 19, 2019
Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomesLibin Deng, Wang Jiang, Xiaoning Wang, et al.
BMC Public Health|September 21, 2015
Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in ChinaHongqin Xu, Ge Yu, Haibo Sun, et al.
Antiviral Therapy|October 1, 2019
Real-world clinical outcomes among individuals with chronic HCV infection in China: CCgenos studyHuiying Rao, Qing Xie, Jia Shang, et al.
Journal of Viral Hepatitis|September 19, 2023
Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-upHua He, Yanhua Wu, Zhifang Jia, et al.
Plos One|October 1, 2015
Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese PopulationGe Yu, Xiumei Chi, Ruihong Wu, et al.
Cellular & Molecular Immunology|February 17, 2015
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5AChen Yang, Xinhao Zhao, Dakang Sun, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Scientific Reports|February 15, 2019
Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKDHui Zhang, Hongqin Xu, Ruihong Wu, et al.
Journal of Hepatocellular Carcinoma|October 30, 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese PatientsMiaoxia Liu, Ruihong Wu, Xu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2019
Hepatitis B Virus-Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human MonocytesHongxiao Song, Guangyun Tan, Yang Yang, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Journal of Hepatology|March 19, 2019
Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomesLibin Deng, Wang Jiang, Xiaoning Wang, et al.
BMC Public Health|September 21, 2015
Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in ChinaHongqin Xu, Ge Yu, Haibo Sun, et al.
Antiviral Therapy|October 1, 2019
Real-world clinical outcomes among individuals with chronic HCV infection in China: CCgenos studyHuiying Rao, Qing Xie, Jia Shang, et al.
Journal of Viral Hepatitis|September 19, 2023
Risk-stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10-year follow-upHua He, Yanhua Wu, Zhifang Jia, et al.
Plos One|October 1, 2015
Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese PopulationGe Yu, Xiumei Chi, Ruihong Wu, et al.
Cellular & Molecular Immunology|February 17, 2015
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5AChen Yang, Xinhao Zhao, Dakang Sun, et al.
Pageof 28